EBODAC is a consortium dedicated to enhancing Ebola vaccination programs by ensuring timely delivery to the appropriate individuals. It has supported clinical trials for Ebola vaccines developed by Janssen and Merck in Sierra Leone and is preparing for future vaccine rollouts through initiatives centered on communication, community engagement, and technology. Grameen is implementing a mobile health platform to improve vaccine adherence by providing essential information, services, and tracking capabilities. Furthermore, Grameen is launching a Mobile Training and Support (MOTS) service that utilizes IVR technology to train community health workers on vaccination and disease surveillance, offering audio training content in local languages. The health focus areas include communicable diseases.